ANL 33.80 Increased By ▲ 1.05 (3.21%)
ASC 15.13 Increased By ▲ 0.75 (5.22%)
ASL 25.50 No Change ▼ 0.00 (0%)
AVN 95.50 Decreased By ▼ -0.20 (-0.21%)
BOP 9.17 Increased By ▲ 0.02 (0.22%)
BYCO 10.23 Increased By ▲ 0.25 (2.51%)
DGKC 137.50 Increased By ▲ 2.20 (1.63%)
EPCL 51.62 Increased By ▲ 0.37 (0.72%)
FCCL 25.00 Increased By ▲ 0.31 (1.26%)
FFBL 25.45 Increased By ▲ 0.95 (3.88%)
FFL 15.70 Increased By ▲ 0.28 (1.82%)
HASCOL 10.90 Increased By ▲ 0.18 (1.68%)
HUBC 86.75 Increased By ▲ 0.01 (0.01%)
HUMNL 7.10 No Change ▼ 0.00 (0%)
JSCL 27.04 Increased By ▲ 0.45 (1.69%)
KAPCO 40.00 Increased By ▲ 0.80 (2.04%)
KEL 4.15 Increased By ▲ 0.04 (0.97%)
LOTCHEM 14.80 Increased By ▲ 0.08 (0.54%)
MLCF 47.59 Increased By ▲ 0.75 (1.6%)
PAEL 38.30 Increased By ▲ 1.20 (3.23%)
PIBTL 11.91 Increased By ▲ 0.08 (0.68%)
POWER 10.70 Increased By ▲ 0.20 (1.9%)
PPL 90.97 Decreased By ▼ -0.53 (-0.58%)
PRL 27.45 Increased By ▲ 1.63 (6.31%)
PTC 8.81 Decreased By ▼ -0.09 (-1.01%)
SILK 1.40 No Change ▼ 0.00 (0%)
SNGP 43.75 Increased By ▲ 2.68 (6.53%)
TRG 147.70 No Change ▼ 0.00 (0%)
UNITY 31.20 Increased By ▲ 0.72 (2.36%)
WTL 1.52 Decreased By ▼ -0.02 (-1.3%)
BR100 5,016 Increased By ▲ 30.84 (0.62%)
BR30 26,130 Increased By ▲ 297.73 (1.15%)
KSE100 46,158 Increased By ▲ 193.53 (0.42%)
KSE30 19,308 Increased By ▲ 71.8 (0.37%)

Sputnik V

Argentine lab says agrees deal to produce Russia's Sputnik V vaccine
Business & Finance

Argentine lab says agrees deal to produce Russia's Sputnik V vaccine

  • Argentina was one of the first countries in the region to sign an agreement with Russia to buy Sputnik V and has already received 1.22 million doses from the Russian Gamaleya Institute.
  • This potential development will be carried out with the participation of Hetero Labs Limited, a laboratory established in India, with whom Laboratorios Richmond has had a strategic alliance for more than 25 years.
Published 26 Feb, 2021 08:09pm
Egypt registers Russia's Sputnik V COVID-19 vaccine
World

Egypt registers Russia's Sputnik V COVID-19 vaccine

  • RDIF, Russia's sovereign wealth fund responsible for marketing the vaccine abroad, said Sputnik V had been approved by the Egyptian Drug Authority using an emergency use authorisation procedure. Tunisia and Algeria have already approved the shot.
Published 24 Feb, 2021 05:49pm
Israel blocks shipment of Sputnik V vaccine to the Gaza Strip
World

Israel blocks shipment of Sputnik V vaccine to the Gaza Strip

  • Israel has blocked 1000 doses of the Russian-made Sputnik V coronavirus vaccine, intended for frontline medical workers and key personnel in the tumultuous Gaza Strip.
  • The Gaza Strip has yet to any vaccines, with over 53,000 cases and 537 deaths since the start of the pandemic, and limited support in the management of this public health crisis.
Updated 16 Feb, 2021 06:25pm
Russian Vaccine Team to Conduct Combined Trial with Chinese Counterparts
World

Russian Vaccine Team to Conduct Combined Trial with Chinese Counterparts

  • Russian developers are in talks with China's CanSino Biologics Inc., in an effort to test a combined regimen of their shots to better protect against new virus strains.
  • The Russian Direct Investment Fund, a partner in the Sputnik V vaccine program, forged a preliminary agreement with the CanSino and Petrovax Pharm, to reportedly conduct testing in Russia.
Updated 15 Feb, 2021 10:57am
Hungary to start vaccinations with Russian COVID-19 shot
World

Hungary to start vaccinations with Russian COVID-19 shot

  • Cecilia Muller said the first 2,800 doses of Sputnik would be given to those who have registered for inoculations.
  • "It... can be used with appropriate caution in case of certain chronic diseases," she told a briefing.
Published 09 Feb, 2021 06:08pm
Hungary may start Russia's Sputnik shots next week, says PM
World

Hungary may start Russia's Sputnik shots next week, says PM

  • It is scheduled to receive 600,000 doses of Sputnik and another half a million doses of China's Sinopharm vaccine this month.
  • Orban said so far 264,530 Hungarians - healthcare workers and the most vulnerable elderly - have received at least one shot from the Pfizer and Moderna vaccines.
Published 05 Feb, 2021 05:48pm
Russia's Sputnik V vaccine 92% effective in fighting COVID-19
World

Russia's Sputnik V vaccine 92% effective in fighting COVID-19

  • Experts said the Phase III trial results meant the world had another effective weapon to fight the deadly pandemic and justified to some extent Moscow’s decision to roll out the vaccine before final data had been released.
  • The results were based on data from 19,866 volunteers, of whom a quarter received a placebo, the researchers, led by the Gamaleya Institute’s Denis Logunov, said in The Lancet.
Published 02 Feb, 2021 07:51pm